PTC Therapeutics Inc. has announced the approval of non-statutory stock options and restricted stock units (RSUs) as part of a new compensation plan for 34 new employees, effective June 16, 2025. The company has granted stock options for 12,725 shares of common stock and 27,790 RSUs, each unit entitling the holder to one share upon vesting. The stock options, priced at $51.87 per share, have a 10-year term and vest over four years, with 25% vesting on the first anniversary of the hire date and the remainder vesting quarterly. The RSUs will vest annually over four years. These awards are part of the Nasdaq inducement grant exception, designed to attract new talent.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY14452) on June 19, 2025, and is solely responsible for the information contained therein.